Flavone-based novel antidiabetic and antidyslipidemic agents

J Med Chem. 2012 May 24;55(10):4551-67. doi: 10.1021/jm201107g. Epub 2012 May 2.

Abstract

The hybrid congeners 62-90 of 6- and 7-hydroxyflavones with aminopropanol have been synthesized and evaluated for their antidiabetic activity in sucrose-challenged low-dosed streptozotocin (STZ)-induced diabetic rats and db/db mice. The optical enantiomers 70a, 70b, 90a, and 90b of two congeners 70 and 90 exhibiting consistent antidiabetic and antidyslipidemic activities were also prepared, and their antidiabetic activity results indicate its association mainly with S isomers. These compounds also lower cholesterol and TG profiles while improving high-density lipoprotein cholesterol to CHOL ratio in db/db mice. The bioavailability of compound 70 and its isomer varies between 27 and 29% whereas that of the more polar compound 90a is poor as determined in rat by oral and intraperitoneal administrations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biological Availability
  • Cholesterol / blood
  • Cricetinae
  • Diabetes Mellitus, Experimental / drug therapy*
  • Dose-Response Relationship, Drug
  • Flavones / chemical synthesis*
  • Flavones / chemistry
  • Flavones / pharmacology
  • Hypoglycemic Agents / chemical synthesis*
  • Hypoglycemic Agents / chemistry
  • Hypoglycemic Agents / pharmacology
  • Hypolipidemic Agents / chemical synthesis*
  • Hypolipidemic Agents / chemistry
  • Hypolipidemic Agents / pharmacology
  • Insulin / blood
  • Male
  • Mesocricetus
  • Mice
  • Mice, Inbred C57BL
  • Rats
  • Rats, Sprague-Dawley
  • Rats, Wistar
  • Stereoisomerism
  • Streptozocin
  • Structure-Activity Relationship
  • Triglycerides / blood

Substances

  • Flavones
  • Hypoglycemic Agents
  • Hypolipidemic Agents
  • Insulin
  • Triglycerides
  • Streptozocin
  • Cholesterol